View in EDS HTML Full Text PDF Full Text

A Randomized, Double‐Blind Study Comparing Pharmacokinetics and Pharmacodynamics of Proposed Biosimilar ABP 798 With Rituximab Reference Product in Subjects With Moderate to Severe Rheumatoid Arthritis.

Saved in:
Bibliographic Details
Title: A Randomized, Double‐Blind Study Comparing Pharmacokinetics and Pharmacodynamics of Proposed Biosimilar ABP 798 With Rituximab Reference Product in Subjects With Moderate to Severe Rheumatoid Arthritis.
Authors: Burmester, Gerd1 (AUTHOR) gerd.burmester@charite.de, Chien, David2 (AUTHOR), Chow, Vincent3 (AUTHOR), Gessner, Melissa4 (AUTHOR), Pan, Jean2 (AUTHOR), Cohen, Stanley5 (AUTHOR)
Source: Clinical Pharmacology in Drug Development. Nov/Dec2020, Vol. 9 Issue 8, p1003-1014. 12p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:2160763X
DOI:10.1002/cpdd.845